Within the peptide microarray market, Reagents held the strongest position in 2025 with a 56.92% share. This dominance is sustained by the fact that reagents are the core consumable input required for peptide synthesis, assay preparation, sample interaction, and signal detection across routine and repeated workflows. Demand remains closely tied to ongoing experimental volume, making reagent purchasing a recurring requirement for research laboratories, diagnostic development teams, and assay operators. That operational dependence supports the segment’s leadership in the peptide microarray market more consistently than categories linked to periodic or project-based spending.

Services are emerging as the fastest-growing segment in the peptide microarray market as more users seek external support for assay design, custom array development, data interpretation, and specialized testing workflows. Growth is being reinforced by practical adoption patterns: many organizations want access to peptide microarray capabilities without committing to full in-house infrastructure, technical staffing, or method optimization. Compared with reagents, which are purchased within established lab workflows, services gain momentum from expanding demand among users who need flexibility, faster project execution, and access to advanced expertise for more complex applications.

Application Segment Analysis: Disease Diagnostics (Largest Segment) vs Protein Functional Analysis (Fastest-Growing Segment)

Disease Diagnostics accounted for the largest position in the peptide microarray market in 2025, capturing a 41.65% share. its position is backed by the direct utility of peptide microarrays in identifying disease-associated biomarkers, immune responses, and epitope patterns in clinically relevant settings. The application benefits from clearer routine-use relevance than many research-focused areas, as diagnostic workflows depend on reliable, repeatable screening formats that can process multiple targets efficiently. That practical alignment with testing needs helps Disease Diagnostics maintain its leading share in the peptide microarray market.

Protein Functional Analysis is the fastest-growing application in the peptide microarray market because it addresses rising demand for deeper insight into protein interactions, binding behavior, and functional mapping in discovery workflows. Momentum is strongest where researchers need higher-throughput tools to examine biological mechanisms more efficiently than conventional single-target approaches allow. Relative to more established diagnostic use cases, Protein Functional Analysis is gaining pace from expanding research intensity and the need for broader functional characterization in laboratory and therapeutic development environments.